Out of control: Blinding, dose response, and psychosocial controls in psychedelic trials
Published online on September 01, 2025
Abstract
Journal of Psychopharmacology, Ahead of Print.
As psychedelic clinical trials expand in scale and influence, foundational challenges in trial design have come into sharper focus. In this commentary, we examine three interrelated issues: 1) the failure of blinding in psychedelic trials, 2) the ...
As psychedelic clinical trials expand in scale and influence, foundational challenges in trial design have come into sharper focus. In this commentary, we examine three interrelated issues: 1) the failure of blinding in psychedelic trials, 2) the ...